Biosergen AB (publ) (8N10)
Market Open
7 Aug, 06:56
XFRA XFRA Primary 
XSTO €
0. 51
+0.45
+766.0756%
€
1.86M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 0.06
Previous Close Want to track 8N10 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biosergen AB (publ) (8N10) Statistics
Valuation metrics
Market Cap 1.86M
Enterprise value -
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.09
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 2.35M
Float 851.56K
Shares short -
% Held by insiders 0.58%
% Held by institutions 0.06%
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.06
52-Week high 4.72
Beta -0.03
50-Day moving average 1.66
200-Day moving average 3.33
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.01:1
Last split Date 1 Dec 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.68%
Return on equity -1.45%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -40.82M
Diluted EPS (ttm) -1.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 15.37M
Total cash per share (mrq) 6.54
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.95%
Book value per share (mrq) 8.63
Cash Flow
Cash flow statement -35.53M
Levered free cash flow (LFCF) -2.13M
